We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





LumiraDx Demonstrates Transformative Tests and Technologies

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: The innovative, next generation LumiraDx Point of Care Diagnostic Platform (Photo courtesy of LumiraDx)
Image: The innovative, next generation LumiraDx Point of Care Diagnostic Platform (Photo courtesy of LumiraDx)

LumiraDx (London, UK) is presenting its innovative, next-generation point-of-care diagnostics Platform and broad test menu alongside its Fast Lab Solutions at MEDICA 2023.

The LumiraDx Platform is an innovative, next-generation point-of-care system that combines a small, portable instrument, advanced low-cost test strip, and seamless digital connectivity. Its proprietary technology enables it to deliver exceptional point-of-care clinical performance while being simple and easy to use. LumiraDx offers various tests that run on the highly portable LumiraDx Platform, such as the LumiraDx NT-proBNP test which is a quantitative, fingerstick blood assay designed for near-patient testing with lab-comparable results in 12 minutes. It is the only fingerstick NT-proBNP test currently commercially available. The rapid microfluidic immunofluorescence assay can aid in the diagnosis of congestive heart failure (CHF).

LumiraDx also offers its highly sensitive C-Reactive Protein (CRP) point-of-care antigen test that runs on the portable LumiraDx platform which weighs just over a kilogram. The point of care CRP test can be used in multiple clinical settings to help reduce unnecessary antibiotic prescribing that leads to antimicrobial resistance. From a tiny sample of finger-prick blood, the CRP test gives results within four minutes. Additionally, LumiraDx’s HbA1c test for professional use across multiple care settings is used alongside the LumiraDx Platform. The test monitors known diabetic patients’ HbA1c levels and also serves as an aid in screening and identifying patients who may be at risk for developing diabetes. Providing results in less than seven minutes from sample application, the test allows improved efficiency and convenience with on-the-spot diabetes screening and monitoring at the patient’s side.

At MEDICA 2023, LumiraDx is highlighting its LumiraDx INR Test which is an enzyme kinetic assay based on Thrombin activity. The coagulation cascade is activated by the test reagents and INR is calculated from the measured PT-time. Haematocrit is also measured on the strip to ensure patients are within the 25-55% range. The accuracy of the LumiraDx INR Test is comparable to the ACL Elite lab reference method. Another test that supports confident decisions at the point of care with the LumiraDx Platform is the LumiraDx D-Dimer Test which is a rapid microfluidic immunoassay for quantitative determination of D-Dimer. It is the only D-Dimer Test providing fast, accurate, quantitative results in just 6 minutes from a fingerstick blood sample.

Related Links:
LumiraDx 

Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Gold Supplier
D-Dimer Test
Epithod 616 D-Dimer Kit
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Motorized Pipette Controller
AccuHelp

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: Scientists have discovered a new amyloid-forming protein in neurodegenerative disease (Photo courtesy of 123RF)

Discovery of Rogue Protein Paves Way for Diagnostic Test to Detect Early-Onset Dementia

Neurodegenerative disorders are often marked by the buildup of amyloid filament inclusions of specific proteins in the brain. These proteins are critical in diagnosing and treating the associated diseases.... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Three examples of Anthrobots with hair-like cilia in yellow (Photo courtesy of Gizem Gumuskaya)

Tiny Biological Robot Healers Built From Human Cells Could Recognize Bacteria

In a pioneering study, researchers have developed microscopic biological robots, termed Anthrobots, from human tracheal cells. These tiny robots, varying in size from the width of a human hair to the tip... Read more

Technology

view channel
Image: Made-to-order diagnostic tests may soon be on the horizon (Photo courtesy of McGill University)

Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible

Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read more

Industry

view channel
Image: Covaris offers instruments, consumables, and reagents for high-throughput genomic and proteomic analysis (Photo courtesy of Covaris)

PerkinElmer Acquires Covaris to Create Global Life-Sciences and Diagnostics Platform

PerkinElmer, Inc. (Waltham, MA, USA), a global analytical services and solutions provider has acquired Covaris (Woburn, MA, USA), a developer of solutions to empower life science innovations.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.